b, c, e, f, h, i: n = 3 biological replicates
Labeling includes lot numbers, expiration dates, and storage instructions

Target Consumer Segments Adults With Weight Management Goals (2555) : men and women seeking natural appetite control and metabolic support for sustained fat loss Adults With Obesity-related Concerns (3060) : requiring therapeutic supplementation to improve insulin sensitivity, reduce cravings, and support cardiovascular health Busy Professionals (3050) : individuals with high-stress lifestyles choosing convenient gummies to manage weight without prescription solutions Health-conscious Millennials (2540) : proactive consumers exploring natural alternatives to GLP-1 medications for preventative metabolic wellness Seniors (55+) : older adults focusing on blood sugar balance, appetite regulation, and healthy aging through metabolic support Individuals With Emotional Eating Habits (2550) : adults needing preventative appetite management and satiety support for long-term weight control Regional Consumer Demand North America Market Insight : North America shows a growing demand for weight management and metabolic health supplements, with a focus on GLP-1 boosters for improving appetite regulation and glucose metabolism

BPC 157 was given per-orally, in drinking water (10 g/kg or 10 ng/kg, 0.16 g/ml, or 0.16 ng/ml 12 ml/rat/day) till sacrifice, or alternatively, 10 g/kg and 10 ng/kg intraperitoneally once daily
Tirzepatide is better than semaglutide in lowering A1c because of this dual action: patients on the lowest dose of tirzepatide had a -2.01% A1c reduction vs